Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tagen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Stem Cell Reviews|January 24, 2007
Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactionsT C Theoharides, D Kempuraj, M Tagen, et al.
British Journal of Pharmacology|September 23, 2008
Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cellsD Kempuraj, M Tagen, B P Iliopoulou, et al.
International Journal of Immunopathology and Pharmacology|July 13, 2006
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunityM L Castellani, V Salini, S Frydas, et al.
Pharmacological Research|November 18, 2006
Immunological activation of human umbilical cord blood mast cells induces tryptase secretion and interleukin-6, and histidine decarboxilase mRNA gene expressionM L Castellani, A Perrella, D J Kempuraj, et al.
International Journal of Immunopathology and Pharmacology|September 21, 2007
Anti-chemokine therapy for inflammatory diseasesM L Castellani, K Bhattacharya, M Tagen, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2016
Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric EpendymomaV M Daryani, Y T Patel, M Tagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumorsA Italiano, J R Infante, G I Shapiro, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Stem Cell Reviews|January 24, 2007
Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactionsT C Theoharides, D Kempuraj, M Tagen, et al.
British Journal of Pharmacology|September 23, 2008
Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cellsD Kempuraj, M Tagen, B P Iliopoulou, et al.
International Journal of Immunopathology and Pharmacology|July 13, 2006
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunityM L Castellani, V Salini, S Frydas, et al.
Pharmacological Research|November 18, 2006
Immunological activation of human umbilical cord blood mast cells induces tryptase secretion and interleukin-6, and histidine decarboxilase mRNA gene expressionM L Castellani, A Perrella, D J Kempuraj, et al.
International Journal of Immunopathology and Pharmacology|September 21, 2007
Anti-chemokine therapy for inflammatory diseasesM L Castellani, K Bhattacharya, M Tagen, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2016
Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric EpendymomaV M Daryani, Y T Patel, M Tagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumorsA Italiano, J R Infante, G I Shapiro, et al.
Pageof 1